| Literature DB >> 33778923 |
Fábio Santiago1,2,3, Rafaele Tavares Silvestre1,2, Ubirani Barros Otero4, Marianne Medeiros Tabalipa4, Marilza de Moura Ribeiro-Carvalho1,2, Luciano Rios Scherrer5, Ahmed Al-Rikabi3, Thomas Liehr3, Gilda Alves6,7, Maria Helena Ornellas1,2.
Abstract
PURPOSE: Gas station workers (GSWs) are exposed to carcinogenic agents. The aim was to study the association of high somatic chromosome alterations (CAs) rates in the blood of GSWs and the polymorphisms of three genes playing a role in DNA double-strand break repair.Entities:
Keywords: ATM/P1054R; Benzene; Chromosome aberration; Gas station worker; RAD51/G135C
Mesh:
Substances:
Year: 2021 PMID: 33778923 PMCID: PMC8384795 DOI: 10.1007/s00420-021-01652-8
Source DB: PubMed Journal: Int Arch Occup Environ Health ISSN: 0340-0131 Impact factor: 3.015
Demographics data of gas station workers
| Data | Group 1 | Group 2 | Group 1 × Group 2 | Total of workers | Controls | Total of workers × controls ( |
|---|---|---|---|---|---|---|
| Gender | 0.235 | |||||
| Women | 39 (42.4%) | 15 (68.2%) | 54 (47.4%) | 64 (55.7%) | ||
| Men | 53 (57.6%) | 7 (31.8%) | 60 (52.6%) | 51 (44.3%) | ||
| Age (year) | 38.9 (± 12.4) | 38.8 (± 12.51) | 0.900 | 38.84 (± 12.42) | 36.43 (± 12.93) | 0.101 |
| Time of employment (year) | 5.7. (± 6.0) | 4.3 (± 3.8) | 0.574 | |||
| Skin color | 0.638 | 0.100 | ||||
| Black | 25 (27.2%) | 8 (36.4%) | 33 (28.9%) | 20 (18.2%) | ||
| White | 14 (15.7%) | 3 (13.6%) | 17 (14.9%) | 48 (43.6%) | ||
| Brown (Mulatto) | 50 (54.3%) | 10 (45.5%) | 60 (52.6%) | 41 (37.3%) | ||
| Light brown (Native Indians) | 2 (2.2%) | 0 (0.0%) | 2 (1.8%) | 1 (0.9%) | ||
| Yellow (Asiatic) | 1 (1.1%) | 1 (4.5%) | 2 (1.8%) | 0 (0.0%) | ||
| Alcohol consumption | ||||||
| No | 18 (15.8%) | 52 (45.2%) | 1.000 | |||
| Yes | 75 (65.8%) | 51 (44.3%) | ||||
| Stopped drinking | 15 (13.2%) | 5 (4.3%) | ||||
| Never drank | 6 (5.3%) | 7 (6.1%) | ||||
| First trimester of spontaneous abortion | 7 (77.8%) | 1 (11.1%) |
P value < 0.05 was considered significant
Descriptive measures: a (± b), a = average and b = standard deviation
Laboratory data of gas station workers
| Data | Group 1 | Group 2 | Group 1 × Group 2 | Total of workers | Controls | Total of workers × controls ( |
|---|---|---|---|---|---|---|
| Platelets (109/L) | 254.16 (± 58.83) | 255.52 (± 70.85) | 0.969 | 254.43 (± 60.99) | 278.29 (± 49.70) | |
| Gamma-GT (U/L) | 37.17 (± 39.40) | 28.81 (± 12.61) | 0.819 | 35.74 (± 35.86) | 27.00 (± 37.30) | |
| Direct bilirubin (mg/dL) | 0.39 (± 0.17) | 0.34 (± 0.15) | 0.223 | 0.14 (± 0.05) | 0.16 (± 0.07) | |
| Leukocytes (/μL) | 7318.1 (± 2102.3) | 7226.2 (± 1291.2) | 0.795 | 7300.22 (± 1966.01) | 7778.61 (± 1980.38) | 0.066 |
| Neutrophils (%) | 55.41 (± 9.80) | 55.78 (± 8.36) | 1.00 | 55.49(± 9.51) | 59.46 (± 10.92) | |
| Eosinophils (%) | 3.10 (± 2.76) | 2.73 (± 1.61) | 0.951 | 3.03 (± 2.58) | 2.14 (± 3.09) | |
| Basophils (%) | 0.42 (± 0.34) | 0.33 (± 0.23) | 0.577 | 0.40 (± 0.32) | 0.27 (± 0.43) | |
| Typical lymphocytes (%) | 33.62 (± 8.92) | 35.05 (± 7.89) | 0.385 | 33.89 (± 8.72) | ±32.44 (±9.79) | 0.152 |
| Monocytes (%) | 7.40 (± 2.04) | 6.24 (± 1.55) | 7.18 (± 2.00) | 5.42 (± 1.95) | ||
| Reticulocytes (%) | ±1.13 (±0.38) | 1.19 (±0.30) | 0.209 | 1.15 (± 0.36) | 1.27 (± 0.46) | 0.080 |
| Women | ||||||
| Erythrocytes (million/μL) | 4.48 (± 0.22) | 4.31 (± 0.35) | 0.148 | 4.44 (± 0.37) | 4.62 (± 0.48) | 0.056 |
| Hemoglobin | 13.06 (± 1.1) | 12.54 (± 1.09) | 0.117 | 12.92(± 1.11) | 13.58 (± 1.88) | |
| Hematocrit (%) | 38.76 (± 2.98) | 37.42 (± 3.02) | 0.216 | 38.40(± 3.02) | 40.18 (± 3.56) | |
| Mean corpuscular volume (fl) | 86.66 (± 5.21) | 86.86 (± 3.73) | 0.845 | 86.72 (± 4.82) | 87.12 (± 5.13) | 0.511 |
| Men | ||||||
| Erythrocytes (million/μL) | 4.98 (± 0.37) | 4.95 (± 0.11) | 0.904 | 4.98 (± 0.35) | 4.72 (± 0.45) | |
| Hemoglobin | 14.47 (± 1.13) | 14.49 (± 0.71) | 0.884 | 14.47 (± 1.08) | 13.82 (± 2.08) | |
| Hematocrit (%) | 42.37 (± 2.86) | 42.51 (± 1.55) | 1.000 | 42.38 (± 2.72) | 42.23 (± 3.71) | 0.370 |
| Mean corpuscular volume (fl) | 84.90 (± 4.89) | 84.90 (± 2.42) | 0.645 | 85.42 (± 4.35) | 88.07 (± 5.07) | |
P value < 0.05 was considered significant
Normal values: Platelets 150–400 109/L; gamma-GT 8-71 U/L; direct bilirubin up to 0.3 mg/dL; leukocytes 4000–10,000/μL; neutrophils 40–75%; eosinophils 1–6%; basophils 0–1%; typical lymphocytes 20–45%; monocytes 2–10%, reticulocytes 0.5–2%; erythrocytes 4.5–6.5 million/μL; hemoglobin 13.5–18 g/dL, hematocrit 40–54%, mean corpuscular volume 76–96 fl. Descriptive measures: a (± b), a = average and b = standard deviation
Fig. 1CAs found in analyses of one female worker. CAs—del(1),der(2),t(2;?), der(4),t(4;?). The homemade probes were conjugated with TexasRed to label chromosome 1 (red), Diethylaminocoumarin (DEAC) for chromosome 2 (lightblue), and fluorescein isothiocyanate (FITC) for chromosome 4 (green). Other chromosomes were counterstained with DAPI (dark blue)
Genotypic frequencies of RAD51/G135C and ATM/P1054R genotypes in 114 gas station workers and 115 controls
| GG | GC | CC | CC | GC | GG | |
|---|---|---|---|---|---|---|
| Group 1 | 59 (64.1%) | 29 (31.5%) | 4 (4.3%) | 70 (79.5%) | 18 (20.5%) | 0 (0.0%) |
| Group 2 | 9 (40.9%) | 10 (45.5%) | 3 (13.6%) | 19 (86.4%) | 2 (9.1%) | 1 (4.5%) |
| Total of workers | 68 (59.6%.) | 38 (33.3%) | 8 (7.0%) | 89 (80.9%) | 20 (18.2%) | 1 (0.9%) |
| Controls | 88 (72.2%) | 24 −(21.1%) | 2 (1.8%) | 92 (82.1%) | 20 (17.9%) | 0 (0.0%) |
| Total | 156 (68.4%) | 63 (27.6%) | 9 (3.9%) | 181 (81.5%) | 40 (18.0%) | 1 (0.4%) |
| Hardy–Weinberg Equilibrium | 0.322 | 0.632 | ||||
| Total workers × controls | 0.930 | |||||
| Group 1 × Group 2 | 0.074 | 0.092 | ||||
P value < 0.05 was considered significant
Descriptive measures: a (± b), a = average and b = standard deviation. (a−b), confidence interval sample, 95%
Associations between genotypic frequencies of RAD51/G135C in 114 GSW and biometrics (cytogenetic and demographic) data
| GG | GC | CC | ||||
|---|---|---|---|---|---|---|
| Gender | ||||||
| Men | 35 (51.5%) | 20 (52.6%) | 6 (75.0%) | 1.000 | 0.275 | 0.702 |
| Ethnicity | ||||||
| Women | 33 (48.5%) | 18 (47.4%) | 2 (25.0%) | |||
| Black | 18 (26.5%) | 12 (31.6%) | 3 (37.5%) | 0.555 | 0.164 | 0.395 |
| Mulatto | 40 (58.8%) | 18 (47.4%) | 3 (37.5%) | |||
| White | 9 (13.2%) | 6 (15.8%) | 1 (12.5%) | |||
| Asiatic | 0 (0.0%) | 1 (2.6%) | 1 (12.5%) | |||
| Native Indians | 1 (1.5%) | 1 (1.5%) | 0 (0.0%) | |||
| Number of abnormal metaphases per subject | 0.59 (± 1.4) | 0.76 (± 1.00) | 1.63 (± 1.6) | |||
| Number of chromosomal aberrations per subject | 1.63 (± 1.92) | 0.84 (± 1.94) | 1.03 (± 1.33) | |||
P value < 0.05 was considered significant
Descriptive measures: a (± b), a = average and b = standard deviation
Associations between genotypic frequencies of RAD51/G135C and types of chromosome alterations
|
|
|
| ||||
|---|---|---|---|---|---|---|
| GG | GC | CC | ||||
| Translocations | ||||||
| 0 | 58 (85.3%) | 26 (68.4%) | 6 (75.0%) | 0.133 | 0.769 | 0.126 |
| 1 | 6 (8.8%) | 7 (18.4%) | 1 (12.5%) | |||
| 2 | 3 (4.4%) | 4 (10.5%) | 1 (12.5%) | |||
| 4 | 0 (0.0%) | 1 (2.6%) | 0 (0.0%) | |||
| 5 | 1 (1.5%) | 0 (0%) | 0 (0.0%) | |||
| Chr. fragments | ||||||
| 0 | 64 (94.0%) | 30 (78.9%) | 8 (100.0%) | 1.000 | ||
| 1 | 2 (2.9%) | 8 (21.1%) | 0 (0.0%) | |||
| 2 | 1 (1.5%) | 0 (0%) | 0 (0.0%) | |||
| 3 | 1 (1.5%) | 0 (0%) | 0 (0.0%) | |||
| Chr. Breaks | ||||||
| 0 | 63 (94.0%) | 35 (92.1%) | 6 (75.0%) | 0.787 | 0.245 | |
| 1 | 3 (4.5%) | 3 (7.9%) | 0 (0.0%) | |||
| 2 | 0 (0.0%) | 0 (0.0%) | 2 (25.0%) | |||
| 3 | 1 (1.5%) | 0 (0.0%) | 0 (0.0%) | |||
| Deletions | ||||||
| 0 | 62 (91.2%) | 34 (91.9%) | 6 (75.0%) | 0.731 | 0.197 | 0.774 |
| 1 | 4 (5.9%) | 3 (8.1%) | 1 (12.5%) | |||
| 2 | 2 (2.9%) | 0 (0.0%) | 1 (12.5%) | |||
| Chr. Derivatives | ||||||
| 0 | 65 (95.6%) | 37 (97.4%) | 8 (100.0%) | 0.785 | 1.000 | 0.764 |
| 1 | 1 (1.5%) | 1 (2.6%) | 0 (0.0%) | |||
| 2 | 2 (2.9%) | 0 (0.0%) | 0 (0.0%) | |||
| Inversions | ||||||
| 0 | 68 (100.0%) | 36 (97.3%) | 8 (100.0%) | 0.352 | 1.000 | 0.398 |
| 1 | 0 (0.0%) | 1 (2.7%) | 0 (0.0%) | |||
| Monosomies | ||||||
| 0 | 62 (91.2%) | 36 (94.7%) | 6 (75.0%) | 1.000 | 0.248 | 1.000 |
| 1 | 4 (5.9%) | 2 (5.3%) | 1 (12.5%) | |||
| 2 | 1 (1.5%) | 0 (0.0%) | 1 (12.5%) | |||
| 5 | 1 (1.5%) | 0 (0.0%) | 0 (0.0%) | |||
| Trisomies | ||||||
| 0 | 67 (98.5%) | 37 (97.4%) | 8 (100.0%) | 1.000 | 1.000 | 1.000 |
| 1 | 1 (1.5%) | 1 (2.6%) | 0 (0.0%) | |||
P value < 0.05 was considered significant
Descriptive measures: a (± b), a = average and b = standard deviation
Statistical analysis of ATM/P1054R genotypes
| CC | CG | GG | |||
|---|---|---|---|---|---|
| Gender | |||||
| Men | 42 (47.2%) | 14 (66.7%) | 1 (100.0%) | 0.097 | 0.146 |
| Women | 47 (52.8%) | 7 (33.3%) | 0 (0.0%) | ||
| Ethnicity | |||||
| Black | 25 (27.8%) | 7 (33.3%) | 0 (0.0%) | 1.000 | 0.976 |
| Brown | 47 (52.2%) | 11 (52.4%) | 1 (100.0%) | ||
| White | 14 (15.6%) | 3 (14.3%) | 0 (0.0%) | ||
| Asian | 2 (2.2%) | 0 (0.0%) | 0 (0.0%) | ||
| Native American | 2 (2.2%) | 0 (0.0%) | 0 (0.0%) | ||
| Number of abnormal metaphases per subject | 0.74 (± 1.36) | 0.62 (± 1.12) | 1 ( | 0.924 | 0.913 |
| Number of chromosomal aberrations per subject | 1.01 (± 1.85) | 0.71 (± 1.35) | 2 ( | 0.517 | 0.965 |
Descriptive measures: a (± b), a = average and b = standard deviation
Statistical analysis of ATM/P1054R genotypes and chromosome alterations
| CC | CG | GG | |||
|---|---|---|---|---|---|
| Translocations | |||||
| 0 | 71 (78.9%) | 16 (76.2%) | 0 (0.0%) | 0.771 | 0.781 |
| 1 | 10 (11.1%) | 4 (19.0%) | 0 (0.0%) | ||
| 2 | 7 (7.8%) | 1 (4.8%) | 0 (0.0%) | ||
| 4 | 1 (1.1%) | 0 (0.0%) | 0 (0.0%) | ||
| 5 | 1 (1.1%) | 0 (0.0%) | 0 (0.0%) | ||
| Chr. Fragments | |||||
| 0 | 78 (87.6%) | 20 (95.2%) | 0 (0.0%) | 0.793 | 0.662 |
| 1 | 9 (10.1%) | 1 (4.8%) | 0 (0.0%) | ||
| 2 | 1 (1.1%) | 0 (0%) | 0 (0.0%) | ||
| 3 | 1 (1.1%) | 0 (0%) | 0 (0.0%) | ||
| Chr. breaks | |||||
| 0 | 84 (93.3%) | 19 (90.5%) | 0 (0.0%) | 0.352 | 0.054 |
| 1 | 5 (5.6%) | 1 (4.8%) | 0 (0.0%) | ||
| 2 | 0 (0.0%) | 1 (4.8%) | 2 (100.0%) | ||
| 3 | 1 (1.1%) | 0 (0.0%) | 0 (0.0%) | ||
| Deletions | |||||
| 0 | 79 (87.8%) | 20 (95.2%) | 0 (0.0%) | 0.275 | 0.279 |
| 1 | 9 (10.0%) | 0 (0.0%) | 0 (0.0%) | ||
| 2 | 2 (2.2%) | 1 (4.8%) | 0 (0.0%) | ||
| Chr. derivatives | |||||
| 0 | 87 (96.7%) | 20 (95.2%) | 0 (0.0%) | 0.573 | 0.589 |
| 1 | 1 (1.1%) | 1 (4.8%) | 0 (0.0%) | ||
| 2 | 2 (2.2%) | 0 (0.0%) | 0 (0.0%) | ||
| Inversions | |||||
| 0 | 89 (98.9%) | 21 (100.0%) | 0 (0.0%) | 1.000 | 1.000 |
| 1 | 1 (1.1%) | 0 (2.7%) | 0 (0.0%) | ||
| Monosomies | |||||
| 0 | 82 (91.1%) | 19 (90.5%) | 0 (0.0%) | 0.799 | 0.808 |
| 1 | 5 (5.6%) | 2 (9.5%) | 0 (0.0%) | ||
| 2 | 2 (2.2%) | 0 (0.0%) | 0 (0.0%) | ||
| 5 | 1 (1.1%) | 0 (0.0%) | 0 (0.0%) | ||
| Trisomies | |||||
| 0 | 88 (97.8%) | 21 (100.0%) | 0 (0.0%) | 1.000 | 1.000 |
| 1 | 2 (2.2%) | 0 (0.0%) | 0 (0.0%) | ||
Descriptive measures: a (± b), a = average and b = standard deviation